584 — AJJ Medtech Holdings Income Statement
0.000.00%
Last trade - 00:00- SG$10.27m
- SG$14.61m
- SG$3.19m
Annual income statement for AJJ Medtech Holdings, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.319 | 0.596 | 1.61 | 2.32 | 3.19 |
| Cost of Revenue | |||||
| Gross Profit | 0.271 | 0.312 | 0.699 | 0.587 | 1.18 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.98 | 4.52 | 4.12 | 6.14 | 6.03 |
| Operating Profit | -1.66 | -3.93 | -2.5 | -3.81 | -2.84 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -1.74 | -3.98 | -2.56 | -3.87 | -2.93 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.73 | -3.7 | -2.56 | -3.87 | -2.93 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.7 | -4.24 | -2.53 | -3.87 | -2.93 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.7 | -4.24 | -2.53 | -3.87 | -2.93 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.004 | -0.003 | -0.003 | -0.002 |